About Journal

Vaccine Research (Vac. Res.) is an official scientific bi-annual publication of Pasteur Institute of Iran. This interdisciplinary journal publishes the original high-quality research papers that contribute to the field of vaccinology - all original paper submissions across basic and clinical medical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and other related areas are welcomed.
The goal of this interdisciplinary peer-reviewed open-access journal is to provide a forum to discuss all aspects of vaccinology. It is targeted towards medical professionals who are interested in vaccines and vaccination. It serves as an interface between academics, those in research and development, and workers in the field of vaccinology. Relevant topics range from basic medical research through to applications, safety and legislation. It was first published on June 2013 and approved by the Ministerial Commission for Accreditation of Iranian Medical Journals on June 14, 2015. The journal accepts original articles, review articles, short communications reporting clinical and basic research studies, case studies, clinical trials, etc. of significant scientific and ethical standards.
All papers are subject to a double-blind reviewing process. The submitted papers will be published after a special review as well as the approval of the editorial board. The honorable professors and researchers are highly appreciated if they visit this website, register, submit and set up their papers based on the Instructions to Authors. Therefore, visiting in person or calling the journal office are not recommended, so all connections with authors and reviewers are done through the website.
Salient Features of the Journal:
- All Authors will get a soft copy of the certificate, letter of acceptance, reviewer evaluation grading
- All the accepted papers will be open accessible with full PDF download.
- Author will get their acceptance/rejection notification within 2-3 months of submitting the paper.
- Fully archived journal
- High Impact Factor journal
- High visibility and indexing
- Open-access journal
- Peer-reviewed journal
- Rapid/fast track publication
- Reputed editorial board
- Response will be given within 24 hours.
- Strict plagiarism policy.
Bibliographic Information
Title Vaccine Research
Journal Title Abbreviations Vac. Res.
ISSN Print ISSN: 2383-2819 
Online ISSN: 2423-4923
Subject Vaccines.
Vaccines -- Periodicals.
Vaccination -- Periodicals.
Scopus Subject Area and Category: Immunology and Microbiology: Immunology Medicine: Microbiology (medical)
Web of Science Categories: Categories: Immunology | Medicine, Research & Experimental | Veterinary Medicine/Animal Health
Coverage * Human and veterinary vaccines:
    - Infectious diseases
    - Non-infectious diseases
* Prophylactic and therapeutic, and plant-based vaccines
* Vaccine technology:
          - Vaccine development, efficacy and safety evaluation
          - Immune responses to vaccines
          - Vaccine vectors, adjuvants and immunomodulators
          - Vaccine production and manufacturing
          - Immunologic studies and animal models
* Reverse vaccinology
* Synthetic peptides and novel immunogens
* Protein modeling.
Language English
Start Year 2013 - Vol. 1, No. 1 -
Frequency Bi-annual  
Director-in-Chief Mohammad Reza Aghasadeghi, Ph.D.
Editor-in-Chief Mohammad Reza Aghasadeghi, Ph.D.
Associate Editor Fariborz Bahrami, Ph.D.
Anis Jafari, Ph.D.
Editorial Assistant Seyed Amir Sadeghi
Place of Publication Iran
Publisher Pasteur Institute of Iran
Status Active
Refereed Yes; Double Blind Peer Review.
NLM class No. W1
LC No. QR189
DDC No. 615.372
URL http://vacres.pasteur.ac.ir/
Type of Access Open Access (OA)
Type of License CC-BY-NC: Creative Commons — Attribution 4.0 International.
The Policy of Screening for Plagiarism All manuscripts must be free from plagiarism contents. Manuscripts submitted to the journal of Vaccine Research (Vac. Res.) will be screened for plagiarism using Similarity Check / iThenticate plagiarism detection tools.
All authors are suggested to use plagiarism detection software to do the similarity checking before submitting their manuscript to the journal.
Editors check the plagiarism detection of manuscripts by using Grammarly detection software (www.grammarly.com) and using iThenticate since September 2018. The journal of Vaccine Research will immediately reject papers leading to plagiarism or self-plagiarism.
Whenever it is determined that manuscript has not complied with the plagiarism rules, the article is rejected (before accepting) and if it has been published (after accepting) it will be removed from the published list and placed in the withdrawn list (returned articles because of Failure to observe plagiarism law).
Type of Publication (Processing Charges and Publication Charges) No page charges are required from the author.
Full text access: Open Access
Revenue Sources Institutional support, Donations
Type of Material Serial (Periodical)
Description Vaccine Research (Vac. Res.) is an international open-access peer-reviewed journal in English that publishes original research papers, review papers, and clinical studies related to all aspects of vaccinology. This interdisciplinary journal publishes the original high-quality research papers that contribute to the field of vaccinology - all original paper submissions across basic and clinical medical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and other related areas are welcomed.
Copyright owner / Copyright holder Authors retain copyright to their work without restrictions.  The author has full control over the work (e.g. retains the right to reuse, distribute, republish etc.).
Authorship The consent of all authors, as well as related authorities/institutions has been received prior to the submission of the manuscript. The order of the authors (as to be reflected on the published article) has been established. The adding or deleting of authors once the manuscript has been accepted for publication would have to be accompanied by a signed statement of consent of all authors. All authors have contributed significantly to the research. Authors are obligated to participate in the peer review process, providing retractions/ corrections/ amendments when necessary. All conflicts of interest/financial support have been declared.
Open Access Statement Vaccine Research (Vac. Res.) is a fully open-access journal, which means that all articles are available on the Web to all users immediately upon publication. Non-commercial and commercial use and distribution in any medium is permitted, provided the author and the journal are properly credited.
Benefits of open access for authors, include:
- Authors retain copyright to their work.
- Free access for all users worldwide.
- Increased visibility and readership.
- No spatial constraints.
- Rapid publication.
No page charges are required from the author.
Digital Archiving Policy
Vaccine Research (Vac. Res.) works with some organizations as Islamic World Science Citation Database (ISC), Yektaweb, National Digital Archives of Iranian Scholarly Journals, and own server of Pasteur Institute of Iran for maintaining our own digital archive. This makes it possible the permanent availability and preservation of scholarly research and to ensure accessibility by converting and upgrading digital file formats to comply with new technology standards.
Data Citation Data should be cited in the same way as article, book, and web citations and authors are required to include data citations as part of their reference list. Data citation is appropriate for data held within institutional, subject focused, or more general data repositories. It is not intended to take the place of community standards such as in-line citation of GenBank accession codes. When citing or making claims based on data, authors must refer to the data at the relevant place in the manuscript text and in addition provide a formal citation in the reference list. Vaccine Research (Vac. Res.) follows the format proposed by the Joint Declaration of Data Citation Principles: Authors; Year; Dataset title; Data repository or archive; Version (if any); Persistent identifier (e.g. DOI)”.
Data Sharing Policy The journal of Vaccine Research uses the Basic Data Sharing Policy. The journal is committed to a more open research landscape, facilitating faster and more effective research discovery by enabling reproducibility and verification of data, methodology and reporting standards. The journal of Vaccine Research encourages authors to cite and share their research data including, but not limited to: raw data, processed data, software, algorithms, protocols, methods, materials. Authors are encouraged to share or make open the data supporting the results or analyses presented in their article where this does not violate the protection of human subjects or other valid privacy or security concerns.
The journal of Vaccine Research encourages authors to share the data and other artifacts supporting the results in the article by archiving it in an appropriate public repository. Authors should include a Data Accessibility Statement, including a link to the repository they have used, in order that this statement can be published alongside their paper.
The journal of Vaccine Research requires authors of Original Investigation, Case Report, and Special Paper articles to (1) place the de-identified data associated with the manuscript in a repository; and (2) include a Data Availability Statement in the manuscript describing where and how the data can be accessed.
The journal of Vaccine Research defines data as the digital materials underlying the results described in the manuscript, including but not limited to spreadsheets, text files, interview recordings or transcripts, images, videos, output from statistical software, and computer code or scripts. Authors are expected to deposit at least the minimum amount of data needed to reproduce the results described in the manuscript.
Data can be placed in any repository that makes data publicly available and provides a unique persistent identifier, including institutional repositories, general repositories (e.g., Figshare, Open Science Framework, Zenodo, Dryad, Harvard Dataverse, OpenICPSR), or discipline-specific repositories.
The Data Availability Statement should be placed in the manuscript at the end of the main text before the references. This statement must include (1) an indication of the location of the data; (2) a unique identifier, such as a digital object identifier (DOI), accession number, or persistent uniform resource locator (URL); and (3) any instructions for accessing the data, if applicable.
At the point of submission, you will be asked if there is a data set associated with the paper. If you reply yes, you will be asked to provide the DOI, pre-registered DOI, hyperlink, or other persistent identifier associated with the data set(s). If you have selected to provide a pre-registered DOI, please be prepared to share the reviewer URL associated with your data deposit, upon request by reviewers.
Where one or multiple data sets are associated with a manuscript, these are not formally peer reviewed as a part of the journal submission process. It is the author’s responsibility to ensure the soundness of data. Any errors in the data rest solely with the producers of the data set(s).
Please note: As you are submitting your manuscript to the journal of Vaccine Research where submissions are double-blind peer reviewed, the main text file should not include any information that might identify the authors (i.e., Author Name, Address, Conflict of Interest and fund related information). As a data availability statement could reveal your identity, we recommend that you remove this from the anonymized version of the manuscript.
Exceptions to this policy will be made in rare cases in which de-identified data cannot be shared due to their proprietary nature or participant privacy concerns. Exceptions to policy and restrictions on data availability are granted for reasons associated with the protection of human privacy, issues such as biosafety, and/or to respect terms of use for data obtained under license from third parties. Confidential data, e.g., human subject or patient data, should always be anonymized, or permission to share should be obtained in advance. If in doubt, authors should seek counsel from their institution’s ethics committee.
Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper. Below a few examples:
Data Availability Statement:
1. Data associated with this article are available in the Open Science Framework at .
2. The data that support the findings of this study are openly available in [repository name] at http://doi.org/[doi], reference number [reference number].
3. The data that support the findings of this study are openly available in [repository name] at [URL], reference number [reference number].
4. The data that support the findings of this study are available in [repository name] at [URL/DOI], reference number [reference number]. These data were derived from the following resources available in the public domain: [list resources and URLs]

View: 10964 Time(s)   |   Print: 1333 Time(s)   |   Email: 28 Time(s)   |   0 Comment(s)

© 2023 All Rights Reserved | Vaccine Research

Designed & Developed by : Yektaweb

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.